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Objective: Mild traumatic brain injury (mTBI) has high prevalence in the military, among athletes, and in the
general population worldwide (largely due to falls). Consequences can include a range of neuropsychological
disorders. Unfortunately, such neural injury often goes undiagnosed due to the difficulty in identifying symptoms,
so the discovery of an effective biomarker would greatly assist diagnosis; however, no single biomarker has been
identified. We identify several body substances as potential components of a panel of biomarkers to support the
diagnosis of mild traumatic brain injury.
Methods: Our approach to diagnostic biomarker discovery combines ideas and techniques from systems medicine,
natural language processing, and graph theory. We create a molecular interaction network that represents neural
injury and is composed of relationships automatically extracted from the literature. We retrieve citations related to
neurological injury and extract relationships (semantic predications) that contain potential biomarkers. After linking
all relationships together to create a network representing neural injury, we filter the network by relationship
frequency and concept connectivity to reduce the set to a manageable size of higher interest substances.
Results: 99,437 relevant citations yielded 26,441 unique relations. 18,085 of these contained a potential biomarker
as subject or object with a total of 6246 unique concepts. After filtering by graph metrics, the set was reduced to
1021 relationships with 49 unique concepts, including 17 potential biomarkers.
Conclusion: We created a network of relationships containing substances derived from 99,437 citations and filtered
using graph metrics to provide a set of 17 potential biomarkers. We discuss the interaction of several of these
(glutamate, glucose, and lactate) as the basis for more effective diagnosis than is currently possible. This method
provides an opportunity to focus the effort of wet bench research on those substances with the highest potential
as biomarkers for mTBI.
Keywords: Semantic predications, Semantic networks, Natural language processing, Degree centrality, Traumatic
brain injuryIntroduction
The diagnosis and treatment of traumatic brain injury
(TBI) has received considerable attention. The military
community may provide the biggest contribution to this
interest because the signature injury of the wars in Iraq
and Afghanistan is mild TBI (mTBI) [1]. mTBI is some-
times referred to as concussion, although the latter term
is becoming less common in clinical and research con-
texts. The athletic community is also concerned with
this condition, especially football and fighting sports, but* Correspondence: mike.cairelli@nih.gov
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unless otherwise stated.also rugby, hockey, and soccer [2-8]. Although less
newsworthy, falls cause the majority of head injuries in
the US, with nearly 1.7 million TBI cases annually [9].
Worldwide, the annual incidence of mild TBI is esti-
mated to be above 600 per 100,000 and, in addition to
falls, motorcycle and bicycle accidents are also major
causes [10]. As important as improvements in care are
for veterans and athletes, such improvements can have a
much broader impact on the health of communities
around the world.
Although there is a need to improve the treatment of
brain injury, perhaps the most significant hurdle is diag-
nosing mTBI. Current diagnostic standards are adequateThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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symptoms are more easily identifiable, but about 70-
90% of TBI is mild, also known as concussion, and
still difficult to recognize [10]. Additionally, the World
Health Organization estimates that many mild injuries
are not even seen by a health care practitioner because
this lack of obvious and urgent symptoms fails to mo-
tivate patients to seek care [10]. Unfortunately, this
does not mean that there are no long-term sequelae
resulting from mTBI. According to current clinical re-
search, mTBI sequelae include cognitive dysfunction,
post-traumatic stress disorder, depression, anxiety, and
dementia [2,11].
However, there are no currently accepted markers for
clinical diagnosis of mTBI. Different organizations have
created schematic tools for diagnosis, but these are sub-
jective and the organizations do not completely agree on
what constitutes a concussion [12]. For the greatest im-
pact for military applications and throughout the world,
as well as to minimize costs, a blood-based test would
be ideal. Thus far such a test has not been found.
There have been several candidate substances (S100B,
neuron-specific enolase, glial acidic fibrillary protein,
etc.), but none have succeeded for effective diagnosis of
mild injury [13]. Because the search for a single bio-
marker has not succeeded, a composite panel may be
an effective alternative. We present a method to help
facilitate the identification of substances that have
potential as biomarkers, which can then be validated
experimentally.
As demonstrated with systems biology [14], the mo-
lecular interactions that occur after neurological injury
are complex. There may be no serum value for any of
the individual components of this complicated interplay
that are specific to neural injury. However, some specific
combination of these values included in a panel has
much greater potential for diagnostic accuracy. The
first step in investigating which substances belong in
such a panel is to identify the potential candidates for
inclusion. In this paper, we describe a methodology to
provide a list of substances that is intended to estab-
lish a base of current knowledge and provide insight
into the development of a biomarker panel for mTBI
diagnosis. We apply natural language processing to
MEDLINE citations to extract semantic predications,
which we represent as a network of potentially rele-
vant substances interacting with their physiological
environment. These semantic predications are subject-
relation-object triples, where the subjects and objects
are UMLS concepts and the relation is derived from
the UMLS Semantic Network as appropriate for a given
concept pair. We then use network analysis techniques
to identify a list that is focused on highly significant
substances.Background
Systems medicine
Our approach to diagnostic biomarker discovery was in-
spired by systems medicine, the application of systems
biology to medicine. The underlying philosophy looks at
biology as ‘information science’ and is concerned with
the network of molecular interactions that define bio-
logical processes [14,15]. Additionally, disease states are
viewed as a perturbation of these molecular networks
[15]. In the case of traditional TBI biomarker discovery,
the approach has been to seek an individual molecule to
represent a disease state, while disregarding any notion
of a network let alone its perturbation. Wang et al. de-
scribe this approach as pauciparameter, containing an
inadequate amount of information and resulting in inad-
equate characterization [15]. The network must be con-
sidered as a whole, because a network perturbation does
not necessitate that any of the individual molecules are
outside of their normal serum measures, especially at
early stages of disease, when prevention is still possible
or treatment is optimal. They give prostate specific anti-
gen for prostate cancer screening as an example of a fail-
ure of the traditional single marker, pauciparameter
approach [15].
Natural language processing
Natural language processing combines artificial intelligence
and linguistic theory to extract meaning from text, using
statistical machine-learning, hand-written rules, or a com-
bined approach [16]. The data utilized in this study were
provided by SemRep, which extracts semantic predications
from all titles and abstracts in MEDLINE [17]. These pred-
ications take the form of a subject-predicate-object triplet.
The subject and object are mapped to Unified Medical
Language System (UMLS) concepts using MetaMap [18]
and are stored with their UMLS semantic type, whereas
the predicate is mapped to the UMLS Semantic Network
[19]. This provides precise semantic meaning from the
source text. For example, from the sentence in (1), SemRep
extracts the predications in (2).
(1) Basic science and clinical observations supportive of
the role of endothelins in the spasm associated with
stroke and subarachnoid hemorrhage are presented.
(Pubmed ID 15281894)
(2) Endothelin ASSOCIATED_WITH Spasm
Spasm ASSOCIATED_WITH Cerebrovascular
accidentThe results of this process are stored in a predication
database, SemMedDB [20], which has been used to sup-
port a range of biomedical information management
research: identifying novel therapeutic approaches [21],
labeling extracted information from clinical text [22],
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retrieval for physicians [27], retrieving clinical documents
[28], abstraction summarization of biomedical texts [29],
biological entity recognition [30], identifying disease candi-
date genes [31], support for cardiovascular clinical guide-
lines [32,33], interpreting microarray data [34], extracting
research findings from literature [35], and supporting for-
mal models of knowledge representation [36,22].
Networks of semantic predications
Any concept in a set of predications can serve as ei-
ther subject or object in various relationships. For
example, one can imagine the concept Glutamate
appearing in many predications similar to the following:
Glutamate ASSOCIATED_WITH Traumatic Brain Injury,
Glutamate INHIBITS Glutamate Synthase, or Glycine
STIMULATES Glutamate. Similarly, any concept can have
a set of relationships that include it as either the sub-
ject or object. Further, any set of predications can be
represented as a network with each concept symbolized
as a node and each relationship denoted by an edge
(or arc) between the two nodes that represent its
subject and object. A network containing the above
predications is contained in Figure 1.
One of the goals of network theory is to establish sig-
nificance of a given node or relationship. Degree central-
ity is based on the number of connections a node has
and Zhang et al. [37] have shown that it is effective for
identifying nodes in a graph that humans consider im-
portant. We have previously applied degree centrality to
SemRep generated semantic predications to successfully
summarize therapeutic studies [38]. For node (or vertex)
v, the degree centrality is calculated by dividing the total
number of nodes connected to v, deg(v), by the total
number of nodes in the network other than v, n-1:





Figure 1 Network of glutamate predications. Subject and object
concepts are represented as nodes and predicates are represented
as edges. Glutamate is common to all three predications and is,
therefore, the most highly connected node in the network.A simple means of judging the value of a given rela-
tionship is the frequency of the relationship, that is, a
simple count of how many times it occurs in a given set.
When using an automated tool, a single occurrence of a
predication is much more susceptible to computational
error than a predication with multiple instances. There-
fore, a higher frequency may provide more confidence in
the validity of the relationship, but at the same time, a
high frequency is reflective of an abundance of asser-
tions in the literature which is likely to be indicative of a
well-known fact and may be less desirable for novel
discovery.
Incorporation of systems medicine, natural language
processing, and network theory
This methodology combines ideas and techniques from
systems medicine, natural language processing, and net-
work theory. A network of relationships involving sub-
stances is created, but the data source is semantic
predications from MEDLINE citations rather than gen-
omic or other large-scale experimental data as have
often been used for systems medicine. These semantic
predications provide a computable form of the know-
ledge contained in MEDLINE that includes gene, pro-
tein, and metabolite relationships analogous to the
experimental data traditionally used in systems medi-
cine, as well as additional types of relations at the organ-
ism, system, organ, tissue, cell, and molecular level.
Statistical approaches are often used to establish correl-
ation and significance of different components in the ex-
perimental data of systems medicine, whereas a network
of semantic predications provided by SemRep naturally
expresses the network of interactions postulated by sys-
tems approaches. Network filtering techniques are used
to further suggest significance of the individual concepts
and their relationships. By coupling components from
these three fields, a novel method of biomarker discov-
ery is proposed.
Related work
Several manual reviews have been undertaken to survey
potential biomarkers for TBI [39,40] and more specific-
ally mTBI [41-43]. These authors search for citations
specifically detailing clinical research of mTBI bio-
markers and therefore contain only potential biomarkers
that have already been investigated. Another limitation
of the studies is the small number of citations reviewed
(ranging from 26 [42] to 107 [43]) due to the limitations
of human review. Although no automated detection of
potential TBI biomarkers exists in the literature, there
are automatic systems to help diagnose other disorders,
for example diabetes and obesity [44]. Although not re-
lated to mTBI, there is research related to the literature-
based discovery of other types of interaction networks
Figure 2 Overview of methodology. A PubMed search was used to
find citations related to nervous system trauma (NST). SemRep
extracted predications containing chemical substances from these
citations, which were then arranged into a network. The network
was filtered by connectedness (degree centrality) and frequency to
provide a summary view of the most significant relationships.
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ally generates an interaction network detailing gene
involvement in vaccine-related fever using 170,000 cita-
tions from a PubMed search and a vaccine—specific
ontology [45]. Another used citations containing the
PubMed MeSH term human and containing sentences
related to interferon-gamma, from which relationships
were extracted and ranked using graph metrics [46].
Jordan et al. [47] present a keyword search method for
identifying putative biomarkers for breast and lung can-
cer by searching for genes and proteins associated with a
biological fluid keyword and either cancer. However,
none of this work has made use of semantic predica-
tions, as we have, in the formation of an interaction net-
work. There is a large body of work on literature-based
discovery approaches many of which use SemRep se-
mantic predications [26,48-54]. These approaches may
generate systems for discovery [55-58] or are specific
applications to predict various phenomena such as
interactions between genes and proteins [46,59], can-
cer treatments [60,61], adverse drug reactions [49],
drug-drug interactions [50], drug repurposing [51,62],
asthma gene associations [63], treatments for neovas-
cularization in diabetic retinopathy [52], relations be-
tween psychiatric and somatic diseases [64], genes
related to reactive oxygen species and diabetes [65],
and mechanisms for sleep disturbance [25] and the obesity
paradox [53].
Methods
As shown in Figure 2, citations related to nervous sys-
tem trauma were retrieved from PubMed. From these,
predications were extracted that contain a substance as
the subject or object. These predications were organized
into a single network which is then filtered to select for
the most highly connected and frequent components.
The substances included in this summary network serve
as the list of potential mTBI biomarkers.
Citation search
A PubMed search for all articles containing the MeSH
term Trauma, Nervous System was used to generate a
list of PubMed identification numbers (PMIDs). This
term is a parent to Brain Injuries in the MeSH hierarchy
and also includes terms such as Spinal Cord Injuries and
Cerebrovascular Trauma. The source publications were
limited only in requiring that they included neural injury
as a topic, with no limitations on journal, species, loca-
tion, or type of injury. Although this included non-TBI
injury and models, (e.g., stroke, spinal cord injury,
hypoglossal-nerve injury, etc.), the goal was to undertake
as wide a search as possible in order to retrieve remote
and ignored possibilities, with the assumption that a sig-
nificant level of commonality exists between the variousforms of injury included under this broad heading in
light of their inclusion of common injury pathways such
as inflammation and oxidative damage. 99,437 unique ci-
tations were returned by this search.
Semantic predication selection
Semantic predications were extracted from SemMedDB
using the PMIDs resulting from the above PubMed
search, which yielded 26,441 unique predications. Over-
all, this set contains 6246 unique concepts, including less
informative terms, such as rattus, injury, and patients as
well as more specific terms, such as glutamate, brain-
derived neurotrophic factor, and methylprednisolone.
We then required the predications to contain at least
one concept (subject or object) having a UMLS semantic
type with potential as a substance biomarker (amino acid
sequence; amino acid, peptide, or protein; biologically
active substance; body substance; carbohydrate; carbohy-
drate sequence; chemical; chemical viewed functionally;
chemical viewed structurally; eicosanoid; enzyme; gene
or gene product; gene or genome; hormone; immuno-
logic factor; inorganic chemical; lipid; neuroreactive
substance or biogenic amine; nucleic acid, nucleoside,
or nucleotide; nucleotide sequence; organic chemical;
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stance). If only one of the arguments was of this type,
the other concept could be of any semantic type. This
resulted in the inclusion of some concepts that indi-
cate that the research was performed in animal models
such as Rattus and Animals. We did not discard these
nodes because they allow the inclusion of potential
biomarkers from basic research in the spirit of transla-
tional medicine. Although a given semantic type, for
instance “Pharmaceutical Substance”, was not included
in the list of target semantic types, it could still appear
in a resulting predication if the complimentary subject
or object met the requirements. As an example, in
the predication Dexamethasone INTERACTS_WITH
NF-kappa B, the subject, Dexamethasone, is of type
Pharmaceutical Substance and the object, NF-kappa
B, is of type Amino Acid, Peptide, or Protein. This
predication qualifies for inclusion because of the object,
not the subject. In the predication Dexamethasone
TREATS Rheumatoid Arthritis, the object, Rheumatoid
Arthritis, is of type Disease or Syndrome, so the
predication would not be selected because neither
subject nor object is of an included semantic type.
After applying this limitation, 18,085 unique predica-
tions remained.
Network of predications
These 18,085 predications extracted from neurological
injury MEDLINE citations and containing a potential
biomarker as subject or object were then linked together
as a network. This network represents all of the known
substance activity involved in neurotrauma, as indicated
by the semantic predications included in SemMedDB.
The nodes of the network represent arguments (subject
or object) from the predications, and the edges represent
the predicates or relationships between subjects and ob-
jects. Each subject-object pair might have multiple pred-
icates. For example, both Melatonin INHIBITS Free
Radicals and Melatonin COEXISTS_WITH Free Radicals
may have been asserted in the literature. When counting
edges in the network, each predicate between the same
subject and object in such predications was counted
separately. Additionally, each subject-predicate-object
triplet could have been asserted once in MEDLINE (and
thus in SemMedDB) or as many as dozens of times.
When taking into account each predication extracted
from multiple citations, the network has 6246 total
nodes and 18,085 total edges. When only unique
(different) predications are considered (regardless of the
number citations they were extracted from), the number
of nodes in the network remains 6246, but the number
of edges is 14,085. This is still a rather large network; to
reduce it to more manageable size, further filtering was
carried out.Network filtering: degree centrality
The first cutoff applied was degree centrality. After
attempting several thresholds, a node degree cutoff of
0.0000800641 was empirically chosen to provide a net-
work with more than 50 and fewer than 100 nodes,
thereby providing a humanly readable graph. This degree
correlates to a node having edges connecting to 50 other
nodes. For example, the concept Traumatic Brain Injury
is connected to 295 other nodes with a degree of
0.0004724 and, therefore, is maintained in the network
after degree filtering. However, the concept cyclooxygen-
ase 2 is connected to only 43 concepts with a degree of
0.00006886 and so is eliminated. The 20 most highly
connected concepts are shown in Figure 3, and 20 exam-
ples of the 2688 nodes which had only a single connec-
tion are provided in Figure 4.
Network filtering: frequency of occurrence
Frequency of occurrence was used in conjunction with
degree centrality to increase the saliency of the network.
A given edge (predicate) between highly connected
nodes (arguments) was required to have a frequency of
occurrence of 2 in an attempt to eliminate spurious
extractions while still including rare statements. As an
example, the predication Interleukin-3 DISRUPTS Cell
Death is maintained in the final network because it
occurs twice in the SemMedDB predication set. Be-
cause NADPH Dehydrogenase INTERACTS_WITH
Glial Fibrillary Acidic Protein occurs only a single
time, it is not included in the final network. The most
frequently occurring predications from this set are
provided in Figure 5. This refinement requiring a fre-
quency greater than or equal to 2 and a node degree
greater than or equal to 0.0000800641 (50 or more
connections) resulted in 1021 predications with 49 unique
concepts (see Figure 6).
Substance network visualization
The resulting network was visualized as a network in
Cytoscape [66]. Redundant edges between connected
nodes were reduced to a single edge for visual simplicity.
In addition to the substance concepts targeted, it also
contains non-substance concepts which are coupled to
the substances in the final predication set. An additional
network visualization was produced (Figure 7), reformat-
ted to focus on the resulting potential biomarkers. All
non-candidate concepts were reduced in size and labels
removed. A candidate subnetwork was formed consist-
ing of substance nodes, edges connecting them, and
directly intermediate nodes and edges (single nodes be-
tween two substances if no edge directly connected the
pair). Nodes and edges outside of the candidate subnet-
work were also colored gray to further reduce visual
prominence.
Figure 3 20 most connected nodes in unfiltered network.
Figure 4 20 from the 2688 nodes with only a single predication in the unfiltered network.
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Figure 5 20 most frequent predications in the unfiltered network.
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The final network was analyzed to outline the distribu-
tion of UMLS semantic types and predicates. The se-
mantic types of nodes were sorted and tallied as were
the predicate for each token of the edges.
Substance identification precision
SemMedDB maintains a reference to the specific sen-
tence in the original citation that was the source for each
predication. Each substance in Figure 6 was compared
against this source sentence and evaluated for con-
sistency with the sentence, not for truth value. In other
words, we evaluated only whether the substance occurs
in the text; whether or not the text provided a biomedi-
cally accurate statement was not evaluated at this stage
(however, truth value was addressed in Section Evalu-
ation of biomarker potential). Precision was calculated
for the resulting substance list using the number of cor-
rect substances in the final network and the total num-
ber of substances in the final network as follows:
Precision ¼ Correct Substancesð Þ= Total Identified Substancesð Þ :
Evaluation of biomarker potential
Each of the substances in the final, filtered network
was individually reviewed manually as a potential
mTBI biomarker. The evaluation was based on 3
questions: is there evidence of a change in the level
of this substance during traumatic brain injury, is
this change evidenced in blood, and has the substancebeen previously investigated as a biomarker for trau-
matic brain injury. We searched PubMed with the
query “[substance name] AND traumatic brain injury
AND (serum OR blood)” and the resulting articles




There are a total of 17 substances out of the 49 con-
cepts in the final network. The first version (Figure 6)
shows all concepts (49) and their connections (145),
while in the second (Figure 7), a candidate subnet-
work is emphasized in black containing 17 sub-
stances as labeled nodes and the 48 edges connecting
them. The candidate subnetwork also contains 12
unlabeled non-substance nodes. One node shown in
the complete network was incorrectly identified as
the substance SHAM (salicylhydroxamate) instead of
“sham” (meaning a false experimental action) while
the 17 other substances were correctly extracted, for a
precision of 0.94.
Substance network semantic distribution
As seen in Table 1, the most common predicate in the
final network is LOCATION_OF with 26 instances. This
represents 22% of the 209 total edges. The predicate
PREDISPOSES, which is a clear indicator of biomarker
potential, is significantly lower at 12 edges (5.7%). The
semantic type Amino Acid, Peptide, or Protein was by far
most common with 13 out of the 49 nodes (26.5%) as
Figure 6 Visualization of substance predication network. The network contains 49 nodes and 1021 edges. Multiple edges between a pair of
nodes are represented as a single edge for visual simplicity; therefore edge labels are not included. Abbreviations: FGF2 = fibroblast growth
factor 2, NGFs = nerve growth factors, BDNF = brain-derived neurotrophic factor, NaCl = sodium chloride, APP = amyloid-beta precursor protein,
SOD = superoxide dismutase, NSE = neuron specific enolase, GFAP = glial fibrillary acidic protein, TBI = traumatic brain injury, IL6 = interleukin 6,
NE = norepinephrin, DA = dopamine, SHAM = salicylhydroxamic acid.
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within the subset of substance nodes (Table 3) with 8 of
the 17 (47.1%).Evaluation of biomarker potential
The results of the substance verification in Table 4
provide an estimate of level of interest for further re-
search as a member in a biomarker panel. In general,
the substances show evidence of change in TBI in
the literature, with two exceptions: amyloid beta-
protein precursor and calpain. (Although calpain
itself does not appear in the literature, the calpain-
derived NH2-terminal fragment of α-spectrin frag-
ment does [67]). Timing and degree of change may
also be an issue regarding the effectiveness of some
substances as mTBI biomarkers. Reduced levels of
calcium appear to return to normal within as little as
4 hours of trauma [68]. Glutamate levels increase in
cerebral spinal fluid but there is no evidence for
measurable changes in blood [69-72]. And a conflict
exists in the literature for melatonin. One study re-
ports a decrease in serum melatonin after TBI [73]
while another reports no change in blood but an in-
crease in cerebral spinal fluid [74].Discussion
Most substances identified in this study as worthy of
consideration as mTBI biomarkers fall into four gen-
eral categories: previously studied biomarkers (amyl-
oid beta-protein precursor, brain-derived neurotrophic
factor, fibroblast growth factor 2, glial fibrillary acidic
protein, neuron-specific enolase, S100b); neurotransmitters
(glutamate, dopamine, norepinephrine); inflammation
and cell injury markers (interleukin-6, calpain break-
down products, malondialdehyde, superoxide dismutase);
and ubiquitous substances (glucose, lactate, calcium).
Although all of the resulting substances were reviewed
in depth during the methodology, the following illustrate
the information contained in the resulting mTBI bio-
marker network and the information retrieved during
the validation process. These examples suggest possible
implications for clinical practice retrieved directly from
the research literature.Glutamate
The well-known association between glutamate and TBI
is present in the network as Glutamate ASSOCIATED_
WITH Traumatic Brain Injury (PMID 17014847), but

















Figure 7 Visualization of interaction network of TBI substances. Only
substance nodes are labeled and paths between substance nodes
are colored black for lengths one or two edges. Abbreviations:
FGF2 = fibroblast growth factor 2, BDNF = brain-derived neurotrophic
factor, APP = amyloid-beta precursor protein, SOD = superoxide
dismutase, NSE = neuron specific enolase, GFAP = glial fibrillary acidic
protein, IL6 = interleukin 6, NE = norepinephrin, DA = dopamine.




















Table 2 Semantic type frequency in final network
Amino acid, peptide, or protein 13
Body part, organ, or organ component 5
Biologically active substance 4
Cell 4
Hormone 4
Injury or poisoning 4
Organic chemical 3
Neuroreactive substance or biogenic amine 2
Animal 1
Cell component 1




Patient or disabled group 1
Sign or symptom 1
Steroid 1
Tissue 1
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For instance, Lactate INTERACTS_WITH Glutamate
is extracted from (3) which notes that glutamate is
produced from the metabolism of lactate in TBI,
and perhaps a less familiar relationship, Glutamate
STIMULATES Lactate is extracted from (4), highlighting
glutamate’s role in activating lactate production in a
potentially neuroprotective, estrogen receptor-dependent
manner.
(3) Infusion with … 3-(13)C-lactate produced (13)C
signals for glutamine … indicating tricarboxylic acid
cycle operation followed by conversion of glutamate
to glutamine. (PMID 19700417)
(4) These results suggest a new neuroprotective
mechanism of 17beta-estradiol by activating
glutamate-stimulated lactate production, which is
estrogen receptor-dependent. (PMID 11368971)Glucose and lactate
Glucose and lactate are substances within the network
that (along with calcium) are ubiquitous in the human
system. Within the context of TBI a major concern is
the decrease of available glucose in the brain due to
Table 3 Semantic type frequency of substances in final
network
Amino acid, peptide, or protein 8
Organic chemical 3
Biologically active substance 2
Neuroreactive substance or biogenic amine 2
Gene or genome 1
Hormone 1
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included in our neural injury network as Glucose
COEXISTS_WITH Lactate, which is extracted from (5).
Sentence (6) is another source of the link between
lactate and glucose, but the source sentence provides
the additional knowledge that peripheral blood glu-
cose levels are not isolated from cerebral levels and
lactate production in the TBI brain, while (7) pre-
sents the opposite, that arterial lactate is connected
to cerebral lactate and subsequently cerebral glucose,
represented in our network as Lactate COEXISTS_
WITH Glucose. As suggested in (4) above, the ratio
of glucose to lactate is influenced by glutamate. It
has been suggested that this may be a result of astro-
cytes responding to increased extracellular glutamate
by increasing glycolysis and, thereby, lactate produc-
tion [75].Table 4 Verification of substances in TBI physiology and TBI b
Changes in trauma? Chang
1 Brain-derived neurotrophic factor Yes Yes
2 Fibroblast growth factor 2 Yes Yes
3 Glial fibrillary acidic protein Yes Yes
4 Neuron-specific enolase Yes Yes
5 S100B Yes Yes
6 Amyloid beta-protein precursor Yes No
7 Interleukin-6 Yes Yes
8 Malondialdehyde Yes Yes
9 Superoxide dismutase Yes Yes
10 Glucose Yes Yes
11 Lactate Yes Yes
12 Dopamine Yes Yes
13 Norepinephrine Yes Yes
14 Calcium Yes Yes
15 Melatonin Yes Yes*
16 Glutamate Yes Yes*
17 Calpain No+ No+
*Modest change or conflicting reports. +Although Calpain itself does not change in trau(5) Following TBI, neuron use initially increases, with
subsequent depletion of extracellular glucose,
resulting in increased levels of extracellular lactate
and pyruvate. (PMID 18826359)
(6) Arterial blood glucose significantly influenced signs
of cerebral metabolism reflected by increased
cerebral glucose uptake [and] decreased cerebral
lactate production… (PMID 19196488)
(7) We conclude that arterial lactate augmentation can
increase brain dialysate lactate, and result in more
rapid recovery of dialysate glucose after FPI [fluid
percussion brain injury]. (PMID 10709871)
Biomarker panels
Although there have been a limited number of attempts
to include multiple biomarkers in panels for TBI
[67,76,77], these have not included some of the types of
substances returned in our results. To a large degree the
absence of consideration for such substances may be ex-
plained by their lack of specificity or their ubiquitous
nature. The level of specificity as an analyte for these
neglected substances is significantly higher for an indi-
vidual marker to stand on its own, and substances that
are frequent if not ubiquitous in normal physiology are
not obvious as candidates for TBI identification. Taken
on their own, glucose and calcium levels are not useful
as measures of brain injury. However, a panel of
markers could better represent the complex network of
molecular changes that occur during TBI and changeiomarker research
es in blood? Previously studied? PMIDs
Yes 11585248, 22528282, 20679891
Yes 11320217, 7696886
Yes 16266720, 22528282, 21079180
Yes 16716992, 22528282













ma, its products do change and are found in the blood and have been studied.
a)
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panel ameliorates the lack of specificity – as long as the
panel as a whole provides adequate sensitivity and
specificity.b)
Figure 8 The relative distribution of predication frequency by year.
a) All frequencies. b) Predications that have at least 2 occurrences.
78.8% of predications occurred only once.Limitations of study
These resulting data provide a clinically relevant hypoth-
esis of potential mTBI biomarkers, which requires ex-
perimental validation. In our investigation into the
validity of the results, it was evident that for some of the
substances, especially the previously-studied biomarkers,
the background TBI model-based studies have already
been completed. For others, this is not the case and
basic exploration in models may need to be pursued be-
fore moving towards clinical research.
The current result set is limited to the uppermost ex-
treme of node connectedness and therefore potentially
overlooks less investigated substances that appear in
fewer publications. An elimination of the most frequent
predications may enrich the result set for substances less
familiar and thereby, potentially, more valuable. The
current threshold is principally set to provide a visually
comprehensible network in the result, though such a
visualization is not required. Reducing the threshold for
inclusion would expand the list with significant com-
pounds, including microRNA.
When we filter by frequency of occurrence with a
cutoff of 2 instances we eliminate 78.8% of the predica-
tions. This step risks eliminating predications that
occur only once because they are completely new and
have only been stated once. Figure 8a shows that 7.8%
of predications were from citations in 2010. As seen in
Figure 8b, when all predications that occur only one
time are removed, the 2010 fraction increases to 7.9%.
This shows that there is not a disproportionate elimin-
ation of predications from the most recent citations
and the loss of unique predications due to their novelty
likely plays a much less significant role than the elim-
ination of inaccurate extraction by SemRep. On the
other hand, as SemRep precision continues to improve,
additional attention to date of publication may be
required.Future directions
Creating a map of neural injury interactions offers sig-
nificant potential for basic science research. Additionally,
our refinement of the network to identify the most
significant interactions according to their degree central-
ity and frequency facilitates the quick translation of pub-
lished research data into clinical practice. The resulting
compound list is clearly interesting in the context of
clinical applicability and merits further study. This tech-
nique allows the investigation of potential biomarkers tobe focused, potentially reducing the wet-lab effort and
reducing the time of assay development.
Now that we have outlined a basic methodology, we
would like to compare this method with various other
methods combining information extraction and network
analysis to understand the advantages and disadvantages
to different approaches.
Our current methodology can be expanded as noted
above to include different subsets of substances in the
Cairelli et al. Journal of Biomedical Semantics  (2015) 6:25 Page 12 of 14final result. Additionally, this methodology is not limited
to biomarker discovery but can also be applied to other
areas of medical discovery, including novel therapeutic
targets, drug repurposing, and others.
Conclusion
We have explored the creation of a molecular inter-
action network that represents neural injury and is
composed of semantic predications automatically ex-
tracted from the literature. We achieved our goal of
providing substances with potential as biomarkers to
support the diagnosis of mTBI. The methodology is
based on a network of semantic predications represent-
ing the interaction of substances observed subsequent
to neural insult. Combining semantic predications
of TBI substance interactions into a network in this way
correlates well with systems biology (and by extension,
systems medicine), which is concerned with the com-
plex network interplay of a biological unit and repre-
sents injury and illness as a perturbation to the
network.
Predications were extracted by SemRep and the com-
ponent subject or object concepts were mapped to
nodes and their relationships (predicates) mapped to
edges, creating a network of relations. This network rep-
resents a summary of the physiological and pharmacoge-
nomic space of neurological injury, as presented in the
literature included in MEDLINE. To identify clinically
significant candidates for mTBI biomarkers, the network
was then filtered by degree centrality and frequency,
greatly reducing the density of concepts and relation-
ships. The resulting network produced 17 compounds to
be considered as mTBI biomarkers, both previously
investigated and novel as TBI biomarker candidates. The
interaction of several of these is discussed as the basis
for a panel of biomarkers to more effectively diagnose
mTBI than is currently possible.
Availability of data and software
The predication data (SemMedDB) is available at
skr3.nlm.nih.gov. Degree and frequency filtering java
programs are available at skr3.nlm.nih.gov/mTBI.
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